Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

A 839977, Tocris Bioscience™

Catalog No. 423210
Change view
Click to view available options
Quantity:
10 mg
50 mg
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
42-3210 10 mg
42-325-0 50 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
This item is not returnable. View return policy
Catalog No. 42-3210 Supplier R&D Systems Supplier No. 4232/10
This item is not returnable. View return policy

Potent P2X7 antagonist

Potent P2X7 antagonist; blocks BzATP-evoked calcium influx at recombinant human, rat and mouse P2X7 receptors (IC50 values are 20, 42 and 150 nM respectively). Displays antinociceptive effects in rat and mice models of inflammatory pain. CNS penetrant.

Chemical Identifiers

CAS 870061-27-1
Molecular Formula C19H14Cl2N6O
Molecular Weight (g/mol) 413.262
InChI Key GMVNBKZQJFRFAR-UHFFFAOYSA-N
Synonym 1-2,3-dichlorophenyl-n-2-pyridin-2-yloxy phenyl methyl-1,2,3,4-tetrazol-5-amine, d0m0xc, 1-2,3-dichlorophenyl-n-2-pyridin-2-yloxy benzyl-1h-tetrazol-5-amine, 1-2,3-dichlorophenyl-n-2-2-pyridinyloxy phenyl methyl-1h-tetrazol-5-amine, 1-2,3-dichlorophenyl-n-2-pyridin-2-yloxy phenyl methyl-1h-1,2,3,4-tetrazol-5-amine
PubChem CID 53325875
IUPAC Name 1-(2,3-dichlorophenyl)-N-[(2-pyridin-2-yloxyphenyl)methyl]tetrazol-5-amine
SMILES C1=CC=C(C(=C1)CNC2=NN=NN2C3=C(C(=CC=C3)Cl)Cl)OC4=CC=CC=N4

Specifications

Quantity 10 mg
Formula Weight 413.26
Percent Purity >98%
Chemical Name or Material A 839977
Recommended Storage Store at +4°C
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.